It May Be Possible to Counter Some of the Genetic Risk of Alzheimer’s With These Lifestyle Changes

There hasn’t been much good news about Alzheimer’s lately, between the March announcement by Biogen and Esai that a promising trial of a potential drug treatment failed, and the July decision by Novartis and Amgen to stop their study of another class of therapies for the neurodegenerative …